{"id":"echinacea","rwe":[],"tags":[],"trials":[],"_chembl":{"chemblId":"CHEMBL2109056","moleculeType":"Unknown"},"aliases":["American Cone Flower","N/H"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"14f87aa6-2005-4939-a612-1162bbc5462b","title":"LYMPH TONIC III (ADENOSINUM TRIPHOSPHORICUM DINATRUM, ARNICA MONTANA, BOLDO, CALCAREA IODATA, CALCAREA PHOSPHORICA, CARCINOSIN, ECHINACEA (ANGUSTIFOLIA), GERMANIUM SESQUIOXIDE, HAMAMELIS VIRGINIANA, HEPAR SULPHURIS CALCAREUM, INFLUENZINUM (2024-2025), NAJA TRIPUDIANS, NATRUM SULPHURICUM, PHYTOLACCA DECANDRA, PINUS SYLVESTRIS, PYROGENIUM, SULPHUR, THYROIDINUM (SUIS), UBIDECARENONUM) LIQUID [BIOACTIVE NUTRITIONAL, INC.]"},"ecosystem":[],"_scrapedAt":"2026-03-28T00:36:02.881Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06190028","phase":"NA","title":"Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive Therapy","status":"TERMINATED","sponsor":"Fidia Farmaceutici s.p.a.","startDate":"2023-06-14","conditions":"Dry Eye Syndrome, Glaucoma and Concomitant Dry Eye Syndrome, Ocular Hypertension and Concomitant Dry Eye Syndrome","enrollment":65},{"nctId":"NCT07398885","phase":"NA","title":"Assessing the Impact of Herbal Supplement on Fatigue and Disease Activity in SLE: Results From an 8-Week Randomized Trial","status":"COMPLETED","sponsor":"University Tunis El Manar","startDate":"2024-07-01","conditions":"System; Lupus Erythematosus","enrollment":59},{"nctId":"NCT07388615","phase":"PHASE2","title":"The Effect of Echinacea (Immulant ®) in the Treatment of CRYPTOSPORIDIOSIS in Immunocompromised Children","status":"RECRUITING","sponsor":"Al-Azhar University","startDate":"2026-01-18","conditions":"Cryptosporidium Infection","enrollment":60},{"nctId":"NCT05067998","phase":"","title":"The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature","status":"RECRUITING","sponsor":"Faith A. Richardson","startDate":"2025-12-21","conditions":"Anxiety Disorders and Symptoms, Fibromyalgia, Arthritis","enrollment":25},{"nctId":"NCT06583863","phase":"NA","title":"Parasitic Infections and Ulcerative Colitis: Combining Anti-parasitic and Immunomodulatory Treatments May Achieve Remission","status":"COMPLETED","sponsor":"Benha University","startDate":"2023-09-12","conditions":"Ulcerative Colitis","enrollment":120},{"nctId":"NCT04999098","phase":"PHASE4","title":"Echinaforce COVID-19 Shedding Study","status":"TERMINATED","sponsor":"A. Vogel AG","startDate":"2021-11-15","conditions":"COVID-19 Respiratory Infection, SARS-CoV2 Infection","enrollment":40},{"nctId":"NCT06020001","phase":"NA","title":"Clinical Evaluation of the AP203 Plant Extract Mixture in Adult Patients With Increased Incidence of Viral and/or Bacterial Upper Respiratory Tract Infections","status":"COMPLETED","sponsor":"AronPharma Sp. z o. o.","startDate":"2022-10-14","conditions":"Upper Respiratory Tract Infection Bacterial","enrollment":60},{"nctId":"NCT03959410","phase":"NA","title":"Impact of HPV on a Cohort of Southern Italian Women: Epidemiological, Clinical, Morphological and Microbiological Features","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2019-01-04","conditions":"Cervix Cancer","enrollment":150},{"nctId":"NCT03463018","phase":"PHASE2","title":"Echinacea Angustifolia (AnxioCalm) in Anxiety","status":"TERMINATED","sponsor":"EuroPharma, Inc.","startDate":"2018-06-06","conditions":"Generalized Anxiety Disorder","enrollment":100},{"nctId":"NCT05242718","phase":"NA","title":"Immune Diversity Response to Oral Dosing of Nutritional Health Products in Healthy Participants","status":"COMPLETED","sponsor":"Immunoflex Therapeutics Inc.","startDate":"2021-01-10","conditions":"Immunity Disorders","enrollment":32},{"nctId":"NCT05117385","phase":"NA","title":"The Effect of the Consumption of 4 Botanical Extracts on Immunity in Healthy Adults (B-4-Immune)","status":"UNKNOWN","sponsor":"Givaudan France Naturals","startDate":"2021-11-22","conditions":"Healthy Subject, Immunity","enrollment":115},{"nctId":"NCT04103099","phase":"NA","title":"Impact of HLNatural Immune Supplement on Colds","status":"COMPLETED","sponsor":"Hawthorne Effect Inc.","startDate":"2019-10-16","conditions":"Immune System Diseases","enrollment":200},{"nctId":"NCT05077813","phase":"PHASE2","title":"Utilizing the Crosstalk Among Chicoric Acid, 13-Cis Retinoic Acid(Aerosolized), Minocycline and Vitamin D as a Potent Quadrate Therapy for Treating Patients With Multidrug-resistant TB and Patient With Both Multidrug-resistant TB and COVID-19","status":"UNKNOWN","sponsor":"Kafrelsheikh University","startDate":"2021-12","conditions":"Tuberculosis","enrollment":250},{"nctId":"NCT05002179","phase":"PHASE4","title":"Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections","status":"COMPLETED","sponsor":"A. Vogel AG","startDate":"2020-11-20","conditions":"Respiratory Tract Infections, Common Cold","enrollment":122},{"nctId":"NCT04981314","phase":"PHASE4","title":"Echinacea Drug for Covid-19","status":"UNKNOWN","sponsor":"Jesús R. Requena","startDate":"2021-06-18","conditions":"Covid19","enrollment":230},{"nctId":"NCT03812900","phase":"PHASE2, PHASE3","title":"Superiority of Newly Developed Over Basic Echinacea Formulations for the Treatment of Respiratory Tract Infections","status":"COMPLETED","sponsor":"A. Vogel AG","startDate":"2018-11-27","conditions":"Respiratory Tract Infections","enrollment":246},{"nctId":"NCT02971384","phase":"PHASE3","title":"Echinacea Junior vs Vitamin C in Children 4-12 Years Old","status":"COMPLETED","sponsor":"A. Vogel AG","startDate":"2016-11-25","conditions":"Respiratory Tract Infection Viral","enrollment":203},{"nctId":"NCT01046890","phase":"PHASE4","title":"Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir","status":"COMPLETED","sponsor":"Germans Trias i Pujol Hospital","startDate":"2010-01","conditions":"HIV Infections","enrollment":15},{"nctId":"NCT01347658","phase":"NA","title":"Drug Interactions Between Echinacea Purpurea and Etravirine","status":"COMPLETED","sponsor":"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","startDate":"2011-04","conditions":"HIV","enrollment":15},{"nctId":"NCT02394366","phase":"PHASE2","title":"Topical Salve for Skin Oxygenation and Blood Flow","status":"COMPLETED","sponsor":"National University of Natural Medicine","startDate":"2015-03","conditions":"Skin Oxygenation, Peripheral Perfusion","enrollment":16},{"nctId":"NCT03070314","phase":"PHASE4","title":"Echinaforce Junior Bioavailability Trial","status":"WITHDRAWN","sponsor":"A. Vogel AG","startDate":"2017-02-20","conditions":"Common Cold","enrollment":""},{"nctId":"NCT02345447","phase":"PHASE3","title":"Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of Recurrence","status":"COMPLETED","sponsor":"University Hospital Tuebingen","startDate":"2013-10","conditions":"Acute Otitis Media","enrollment":296},{"nctId":"NCT00860795","phase":"NA","title":"Immunologic Effects of Echinacea","status":"COMPLETED","sponsor":"University of Washington","startDate":"2009-03","conditions":"Upper Respiratory Tract Infections","enrollment":20},{"nctId":"NCT02313545","phase":"PHASE1, PHASE2","title":"Phase I-B Study to Evaluate the Safety, Tolerability and Efficacy of IZN-6NVS for the Treatment of AV and DIV","status":"COMPLETED","sponsor":"Izun Pharma Ltd","startDate":"2014-12","conditions":"Atrophic Vaginitis","enrollment":50},{"nctId":"NCT02134119","phase":"NA","title":"Echinacea-based Supplement Does Not Improve Markers of Performance in Athletes","status":"COMPLETED","sponsor":"University of Georgia","startDate":"2012-01","conditions":"Ineffective Erythropoiesis","enrollment":45},{"nctId":"NCT02003651","phase":"NA","title":"Echinacea and Acute Respiratory Illness","status":"COMPLETED","sponsor":"Appalachian State University","startDate":"2013-11","conditions":"Acute Respiratory Infections","enrollment":40},{"nctId":"NCT02168335","phase":"PHASE2","title":"The Efficacy of OrasaltsTM in the Treatment of Gingivitis","status":"COMPLETED","sponsor":"University of Johannesburg","startDate":"2014-05","conditions":"Gingivitis","enrollment":40},{"nctId":"NCT00773435","phase":"NA","title":"Effects of Echinacea in Children","status":"WITHDRAWN","sponsor":"University of Washington","startDate":"2008-11","conditions":"Upper Respiratory Infections","enrollment":""},{"nctId":"NCT00065715","phase":"PHASE3","title":"Echinacea Versus Placebo Effect in Common Cold (Physician Echinacea Placebo)","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2003-09","conditions":"Common Cold","enrollment":719},{"nctId":"NCT01021995","phase":"PHASE4","title":"Echinacea Safety Study","status":"COMPLETED","sponsor":"A. Vogel AG","startDate":"2009-10","conditions":"Infections","enrollment":757},{"nctId":"NCT01674374","phase":"PHASE2","title":"Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy","status":"WITHDRAWN","sponsor":"Roswell Park Cancer Institute","startDate":"2013-05","conditions":"Mucositis, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx","enrollment":""},{"nctId":"NCT00010465","phase":"PHASE2","title":"Nervous System Manipulation and Botanicals for the Treatment of Recurrent Ear Infections in Children","status":"COMPLETED","sponsor":"National Center for Complementary and Integrative Health (NCCIH)","startDate":"","conditions":"Otitis Media","enrollment":""},{"nctId":"NCT01049373","phase":"PHASE3","title":"Efficacy and Safety of Lymphdiaral Basistropfen (HDC) in the Treatment of Chronic Low-back Pain","status":"COMPLETED","sponsor":"Pascoe Pharmazeutische Praeparate GmbH","startDate":"2003-12","conditions":"Low Back Pain","enrollment":221},{"nctId":"NCT01129128","phase":"NA","title":"Three Arm Trial of Immune Effects of Echinacea","status":"COMPLETED","sponsor":"University of Washington","startDate":"2010-05","conditions":"Upper Respiratory Tract Infections","enrollment":67},{"nctId":"NCT00103012","phase":"PHASE4","title":"Drug Interactions of Echinacea, Ginseng, and Ginkgo Biloba Taken With Lopinavir/Ritonavir in Healthy Volunteers","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2005-01","conditions":"Healthy","enrollment":47},{"nctId":"NCT01396889","phase":"NA","title":"Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years","status":"COMPLETED","sponsor":"Hormozgan University of Medical Sciences","startDate":"2010-05","conditions":"Upper Respiratory Tract Infections","enrollment":100},{"nctId":"NCT00707902","phase":"PHASE3","title":"Clinical Trial for Assessment of Safety and Efficacy of a Echinacea/Sage Spray Compared to a Chlorhexidine/Lidocaine Spray in the Treatment of Acute Sore Throats","status":"COMPLETED","sponsor":"A. Vogel AG","startDate":"2006-02","conditions":"Pharyngitis","enrollment":154},{"nctId":"NCT00689468","phase":"NA","title":"Echinacea Purpurea and Osteopathy in Children With Recurrent Otitis Media","status":"COMPLETED","sponsor":"University of Arizona","startDate":"1999-07","conditions":"Otitis Media","enrollment":90},{"nctId":"NCT00231218","phase":"PHASE3","title":"Echinacea, Propolis and Vitamin C for URI Prevention in Preschoolers","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2006-01","conditions":"Common Cold, Gastroenteritis","enrollment":104},{"nctId":"NCT00029211","phase":"PHASE3","title":"A Trial of Echinacea in Children","status":"COMPLETED","sponsor":"National Center for Complementary and Integrative Health (NCCIH)","startDate":"2000-04","conditions":"Common Cold","enrollment":600},{"nctId":"NCT00032500","phase":"PHASE2","title":"Evaluation of Echinacea for the Common Cold","status":"COMPLETED","sponsor":"National Center for Complementary and Integrative Health (NCCIH)","startDate":"2001-09","conditions":"Common Cold","enrollment":""}],"_emaApprovals":[],"_faersSignals":[{"count":171,"reaction":"FATIGUE"},{"count":149,"reaction":"NAUSEA"},{"count":123,"reaction":"DIARRHOEA"},{"count":118,"reaction":"PAIN"},{"count":117,"reaction":"HEADACHE"},{"count":110,"reaction":"ARTHRALGIA"},{"count":100,"reaction":"DIZZINESS"},{"count":91,"reaction":"DRUG INEFFECTIVE"},{"count":91,"reaction":"DYSPNOEA"},{"count":81,"reaction":"ASTHENIA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":1502,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Echinacea","genericName":"Echinacea","companyName":"National Center for Complementary and Integrative Health (NCCIH)","companyId":"national-center-for-complementary-and-integrative-health-nccih","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}